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Abstract
UDP-N-acetylglucosamine 2 epimerase/N-acetylmannosamime kinase (GNE) is a bifunctional enzyme which catalyzes the
two key sequential steps in the biosynthetic pathway of sialic acid, the most abundant terminal monosaccharide on
glycoconjugates of eukaryotic cells. GNE knock out (GNE KO) mice are embryonically lethal at day E8.5. Although the role of
GNE in the sialic pathway has been well established as well as the importance of sialylation in many diverse biological
pathways, less is known about the involvement of GNE in muscle development. To address this issue we have studied the
role of GNE during in vitro embryogenesis by comparing the developmental profile in culture of embryonic stem cells (ES)
from wild type and from GNE KO E3.5 mice embryos, during 45 days. Neuronal cells appeared rarely in GNE KO ES cultures
and did not reach an advanced differentiated stage. Although primary cardiac cells appeared at the same time in both
normal and GNE KO ES cultures, GNE KO cardiac cells degraded very soon and their beating capacity decayed rapidly.
Furthermore very rare skeletal muscle committed cells were detected in the GNE KO ES cultures at any stage of
differentiation, as assessed by analysis of the expression of either Pax7, MyoD and MyHC markers. Beyond the supporting
evidence that GNE plays an important role in neuronal cell and brain development, these results show that GNE is strongly
involved in cardiac tissue and skeletal muscle early survival and organization. These findings could open new avenues in the
understanding of muscle function mechanisms in health and in disease.
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Introduction
UDP-N-acetylglucosamine 2 epimerase/N-acetylmannosamime
kinase (GNE) is a bifunctional enzyme with 2 distinct domains
which catalyze the two key sequential steps in the biosynthetic
pathway of sialic acid: the epimerase activity synthesizes ManNAc
from UDP-GlcNAc, followed by ManNAc kinase phosphorylation
of ManNAc to generate ManNAc 6-phosphate [1,2]. Three
subsequent steps lead to the synthesis of the active form of sialic
acid, CMP-sialic acid, the donor of sialic acid to the terminal sugar
in a glycan chain.
Sialic acid is the most abundant terminal monosaccharide on
glycoconjugates of eukaryotic cells [3], and as such is involved in
several biological pathways that are crucial in most cells and tissues.
GNE is essential for embryonic development: specific knock-out
inactivation of the gene in mice results in drastic reduction of
sialylation of embryonal cells and in embryonal lethality at day E8.5
[4]. GNE is regulated by several different mechanisms, most
importantly the feed-back inhibition of the epimerase activity by
CMP-sialic acid, the precursor of the final product sialic acid [5].
Mutations in GNE result in 2 pathological manifestations: the first is
caused by a missense mutation in the allosteric binding site for
CMP-sialic acid, preventing its binding thus leading to the very rare
dominant metabolic disease sialuria, characterized by highly
abundant production and secretion of sialic acid by the patients
[6]; the second, hereditary inclusion body myopathy (HIBM), is a
unique recessive neuromuscular disorder characterized by adult-
onset, slowly progressive distal and proximal muscle weakness,
resulting from homozygous or compound heterozygous mutations
that can occur both at the epimerase domain, both at the kinase
domain, or one in each domain of the protein [7]. Marked GNE
deficiency has not been observed in HIBM patients, in fact western
blots show that the GNE protein is expressed at equal levels in
HIBM patients and normal control subjects [8]. Furthermore, no
mislocalization of GNE in skeletal muscle could be documented
[8,9]. However the enzymatic activity of GNE is reduced by about
30% [10–11] but it is not clear whether this reduction affects the
biosynthesis of sialic acid: analysis of muscle cells from patients
carrying the Middle Eastern founder homozygous mutation
M712T, at the kinase domain of the enzyme, revealed a broad
physiological range of bound sialic acid levels overlapping with the
same broad range in normal controls [10,11]. Some reports
however documented sialic acid reduction in some patients with
different mutations in GNE [12,13].
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21389Interestingly, an overall reduction of 25% in membrane bound
sialic acid was observed in various organs of heterozygous GNE
knock out mice [14]. In spite of these biochemical findings those
mice were perfectly healthy and did not develop myopathy or any
other pathological condition, even after 2 years. Thus, the process
by which mutations in GNE lead to the disease is not yet
understood, and the issue of hyposialylation in HIBM muscles is
still unresolved [10–14].
Therefore we and others have hypothesized that GNE plays
additional roles that could eventually explain the relatively mild
and skeletal muscle specific phenotype of HIBM. Knocking out
the GNE gene in mice results in mouse embryos lethality at day
E8.5 and therefore these mice cannot be used as a tool for our
purpose, although the cause of death has not been determined.
In an attempt to unravel novel role(s) of GNE in normal cells,
we have used the embryonic stem cells from wild type and
GNE2/2 mice embryos, to study the differentiation patterns of
these cells during very early development, to various tissues, in
particular skeletal and cardiac muscle.
Materials and Methods
ES cells culture and differentiation
Embryonic stem cells were the kind gift of Dr Ruediger
Horstkorte (Halle, Germany). GNE2/2 cells had been fully
characterized as having no GNE enzymatic activity [4,15].
Cultures were established essentially as described by Wobus A.
et al [16]: ES cells were thawed and cultured on an irradiated
MEFs (mouse embryonic feeders) layer in Dulbecco’s modified
Eagle’s medium (DMEM) (Sigma, Germany) supplemented with
15% heat-inactivated fetal calf serum, 2 mM L-glutamine, 50 U
Penicilline/Streptomycine, 0.1 M nonessential amino acids (Beit
Haemek, Israel), 5610
25 M b-mercaptoethanol )Bio-Rad, USA)
and with 5610
5 units of recombinant human leukemia inhibitory
factor (LIF)/500 ml.
For differentiation, cells were grown in hanging drops to allow
the formation of embryoid bodies (EB). On day 3, 1% of DMSO
(Fluka, Switzerland) was added to the medium in order to favor
skeletal muscle specific differentiation and EBs were grown in
suspension for 3 more days. At day 5, EBs were plated on gelatin
coated tissue culture plates for further differentiation. On average,
2 EBs were plated per well of a 6 well plate. For immunofluo-
rescence, EBs were plated on LAB-TEC chambers slides (Nunc,
Roskilde, Denmark). Cells were kept in culture up to 45 days and
examined at different time points for morphology and specific
markers expression. Time point 0 refers to proliferating ES cells
before EB formation as a hanging drop. Day 5 refers to the plating
day of EBs onto gelatin coated tissue culture plates.
Expression analysis of specific markers by RT-PCR analysis
RNA was extracted from 2 wells of the 6 wells plate, with Tri-
Reagent (Sigma, St. Louis, MO, USA.) at each time point, both
from GNE KO and WT ES differentiated cells, as described by
the manufacturer. RNA was reverse transcribed using random
hexamer primers (Roche, Germany) by the Masterscript reverse
transcriptase enzyme (5 prime, UK) following the protocol
supplied by the manufacturer. The cDNA products were
denatured for 5 min at 95uC, followed by 40 cycles of
amplification with the appropriate primers: 45 sec denaturation
at 95uC, 30 sec annealing at 55 to 72uC (depending on the primer
used), and 30–120 sec elongation at 72uC followed by a final
elongation at 72uC for 5 min. For b-tubulin detection, 30 cycles of
amplification were performed and 25 cycles for NFM. One-fifth of
each RT–PCR reaction was electrophoretically separated on 2%
agarose gels. For MyoR detection the 7500 real-time PCR system
(Applied Biosystems, UK) was used, together with mouse
GAPDH, using power SYBR green master mix (Applied
Biosystems, UK). The expression of the following genes was
studied: Oct4, NFM, bMHC, Pax7, MyoD, MyoR (primer
sequences are given in Table S1). b tubulin and GAPDH were
used for normalization.
Immunofluorescence staining
Cells were grown in LAB-TEC chamber slides (Nunc, Roskilde,
Denmark), permeabilized and fixed with ice-cold methanol
(15 min at 220uC). Cells were blocked in 2% BSA/PBS for
60 min at RT and incubated for 30 min at RT with mouse
monoclonal anti Myosin Heavy Chain antibody (MF-20 hybrid-
oma) (1:5, 54 mg/ml; Developmental Studies Hybridoma Bank,
University of Iowa.) and mouse monoclonal anti desmin antibody (
1:150, Dako) diluted in 2% BSA/PBS. After washing in PBS, cells
were incubated 30 min at RT with goat anti-mouse Cy3-
conjugated antibody (1:200; Jackson ImmunoResearch) diluted
in 1% BSA/PBS. Nuclei were stained by Hoechst (15 min, R.T.,
10 mg/ml; SIGMA).
Microscopic analysis
Light microscope pictures were viewed in CKX41 system
inverted microscope (OLYMPUS, Tokyo, Japan),and photo-
graphed by a C5060 digital camera (Olympus). Immunofluores-
cence was viewed in a BX41 system microscope (UPlanFL N
406/0.75 ,Olympus), photographed by a DP70 microscope digital
camera and analyzed by the DP software (Olympus).
Glycan analysis
For glycan analyses, cell pellets were dissolved in 0.2% SDS, 1%
beta-mercaptoethanol, 0.1% NP40 and homogeneized.
Sialic acid determination. WT and GNE ko stem cell
samples were subjected to sialic acid analysis [17]. Sample aliquots
were hydrolyzed in 3 M acetic acid for 3 h at 80uC. After the
reaction, samples were neutralized with ammonia, then
evaporated. The internal standard, 2-keto-3-deoxy-nonulosonic
acid (KDN), was added and sialic acids were specifically labeled
with 1,2-diamino-4,5-methylene dioxybenzene (DMB, Sigma) for
2.5 h at 56uC using a solution containing 7 mM DMB, 18 mM
sodium disulfite, 0.75 M b-mercaptoethanol. The reaction
products were analyzed by RP-HPLC on a Gemini C18 column
(4,66250 mm, 5 m, Phenomemex, Torrance, CA) by applying a
gradient of water (A) and acetonitrile/methanol (6/4; v/v; B) at
0.5 ml/min. Elution started with 17% B for 10 min followed by an
increase to 35% B within 60 min. Labeled sialic acids were
monitored by fluorescence at lexc 373 nm and lem 448 nm.
Results
ES GNE2/2 differentiating cells proliferate and
differentiate slower than normal ES cells
Mouse ES cells can proliferate and differentiate in vitro. In
certain culture conditions, these cells can differentiate spontane-
ously in to various lineages, in particular to neuronal cells, cardiac
muscle cells and skeletal muscle cells [16]. Since we were
interested in investigating the role of GNE in these tissues, we
used mouse ES cells, wild type and GNE2/2, for our studies, and
followed their differentiating course as described in the Methods
section.
During cell culture expansion prior to the differentiation
process, we noticed that the proliferation rate was about twice
higher in GNE2/2 cells than in normal ES (results not shown), in
GNE in Development of Skeletal and Cardiac Muscle
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these cells. The following examination of embryoid bodies (EBs),
just before plating on tissue culture plates (day 5), showed some
variation in the size and form of individual embryoid bodies, but
with no consistent differences between GNE+/+ and GNE2/2
EBs (Fig. 1A–D). Very soon after plating on gelatin coated tissue
culture plates (Day 5+1), we could already detect differences
between GNE +/+ and GNE2/2 cells (Fig. 1B–E): in wild type
cell cultures, new cells emerged from the EB borders, proliferated
and were able to adhere and spread on the plate surface. In
contrast, the number of cells emerging from the GNE2/2 EBs
was very limited. Five days later (Fig. 1C–F), at day 5+6o f
differentiation, we could still observe a delay in the culture
dynamics of the different cells: GNE+/+ cells covered already the
entire culture surface, whereas the number of cells originating
from the GNE2/2 EB was significantly smaller, indicating either
a much slower proliferation, adherence or/and migration capacity
of GNE 2/2 cells compared to normal. Six days later (Day 5+12),
GNE2/2 cells also covered the entire culture surface, so that no
proliferation rate difference could be detected between the 2
cultures from this time point (data not shown). Cell density
decreased in the plate monolayer in direct correlation with the
distance from the remaining EB aggregate (data not shown). In less
dense regions, bigger cells could be seen to develop further (data
not shown), such as cells displaying a morphology of neuronal cells
which were observed relatively at distance from the EB itself, still
only in the normal cell cultures (Fig. 2A). Most interestingly, at this
time point, we could also see for the first time cells with cardiac
muscle properties, that is which can beat (Video S1): in the more
dense regions of both cultures we observed the beginning of fibers
generation, that are able to contract. We could detect on average
one beating focus per each EB, both in normal and in GNE 2/2
cell cultures.
Atday5+20,theformationoflongfiberscouldbeobserved(Fig.3)
beating at a pace of 60–80 beats/min in normal cultures, as it was 8
daysbefore,butalreadymuchslowerinGNE2/2cultures(Fig.4A).
Also the number of beating foci decreased in the GNE2/2
cultures (Fig. 4B). Ten days later, at day 5+29 and 5+30, the
picture is quite similar to the previous time point: neuronal cells
can be seen only in normal cultures, at the less dense regions, and
Figure 1. Morphology of ES early differentiating cells in culture. The morphology of GNE+/+ (A–C) and GNE2/2 (D–F) ES cells was followed
during differentiation in culture: there is no difference in recently formed EBs, at day 5 of differentiation (A and D). Later in differentiation, GNE2/2 ES
cells emerge (arrows) and proliferate slower (B and E show EBs 1 day after plating on gelatin coated plates-day 5+1; C and F , at day 5+6).
doi:10.1371/journal.pone.0021389.g001
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both cultures (data not shown). However, the number of beating
foci kept decreasing in the GNE2/2 cultures, as well as their
beating pace, 1 to 5 beats/min compared to 50–80 for normal cells
at the same time point. (Fig. 4A–B, Video S2). At this time point,
we could detect the beginning of neuron like cells differentiation
for the first time in the GNE 2/2 (Fig 2B) cultures, although they
appear to develop much slower than in normal cultures and do not
reach an advanced differentiation state as seen in GNE+/+
cultures, even much later in differentiation (at day 45).(Fig. 2B ).
Marker expression analysis
Molecular markers representing the different differentiation
stages of the different tissues were analyzed at various time points.
cDNA was synthesized from RNA extracted from cell cultures of
both GNE+/+ and GNE2/2 origin, at several differentiation
time points, and analyzed by PCR for the expression of various
relevant genes: Oct4 as a marker of proliferating ES cells; NF-M
(medium neurofilament) as a very early marker of neuronal
precursor; cardiac b-MHC (cardiac myosin heavy chain beta)
which is expressed mostly during embryonic development; Pax7 as
a very early marker of skeletal muscle satellite cells commitment;
MyoD, which is one of the earliest markers of myogenic
commitment and is expressed in activated satellite cells, repre-
senting the beginning of the skeletal muscle differentiation process,
and MyoR, a regulator of MyoD [18]. MyoR (for myogenic
repressor), is expressed in undifferentiated myoblasts in culture
and is down-regulated during differentiation. MyoR is also
expressed specifically in the skeletal muscle lineage between days
10.5 and 16.5 of mouse embryogenesis and down-regulated
thereafter during the period of secondary myogenesis. a role for
MyoR as a lineage-restricted transcriptional repressor of the
muscle differentiation program.
The results are showed in Figs 5 and 6. As expected (Fig. 5),
Oct4 is expressed in normal and in GNE 2/2 ES cells at time 0
and at the very beginning of differentiation, up to day 5+5, and
decays thereafter, in line with the beginning of the differentiation
process. NFM is expressed also from the very beginning in normal
ES cells, and its expression is maintained throughout the entire
period examined. In GNE2/2 cells, the expression of NFM is
somewhat delayed and can be detected only around day 5+5. Also
in correlation with the morphology, NFM expression decays with
time and cannot be detected anymore from day 5+27. The cardiac
b-MHC marker can be detected at day 5+12 in normal ES and
even sooner in GNE 2/2 cells, but in contrast to its persistence in
normal ES cells, its expression decreases with time in GNE 2/2
cells. This result is consistent with the morphological data reported
above, which showed the decrease of functionality of GNE2/2
cardiac cells in culture. As markers of skeletal muscle, we
examined the expression of Pax7, and MyoD. We can see an
almost complete lack of both markers in GNE2/2 cells through
the entire examination period, compared to normal ES cells which
behave as expected: Pax7 begins to be expressed at day 5+9 and
disappears around day 5+33, MyoD expression begins somewhat
later, around day 5+12, while the differentiation process continues,
and is continuously expressed till cells become senescent around
Figure 2. Neuronal lineage differentiation is delayed in GNE 2/2 ES cells. Well differentiated neuronal cells can be seen from day 5+12 in
the GNE+/+ ES cells cultures (A), but only from day 5+40 in the GNE2/2 ES cultures (B).
doi:10.1371/journal.pone.0021389.g002
Figure 3. Cardiac fibers formation in ES cell cultures. Cardiac beating fibers (pointed by arrows) are present in both GNE+/+ and in GNE2/2 ES
cultures on day 5+20 after differentiation.
doi:10.1371/journal.pone.0021389.g003
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profile of MyoR a negative regulator of MyoD, which is relatively
stable during all this time period in normal ES cells, but shows a
much higher average expression in GNE2/2 cells (Fig. 6).
Altogether the results of the gene expression analysis strongly
correlate with and support the morphological data.
Immunohistochemistry
Myosin heavy chain (MyHC), a marker of late differentiation of
skeletal muscle, was examined by immunofluorescence. As seen in
Fig. 7, MyHC can be detected in about 10% of the cultured normal
ES cells but not before day 5+12 of differentiation, . Indeed the
MyHC antigen is expressed in myotubes and multinuclear fibers. In
contrast not a single MyHC positive cell could be detected in
GNE2/2 cultures till day 5+20, but even then the positive stained
cellshad amorphologywhichisverydifferentfromthatofGNE+/+
cells: in cultures derived from normal ES cells, skeletal muscle cells
are in a advanced differentiated state represented by very long fused
myotubes generating large organized muscle fibers. In contrast,
GNE2/2 MyHC positive cells consist of single cells more
elongated or of very short multinucleated shapes. At day 5+35,
normal cells begin to show morphological signs of senescence, but
we can still find some fully developed long multinucleated fibers
intact, whereas GNE2/2 cultures are completely devoided of
muscle fibers and only very few myotubes can be observed. These
results indicate that skeletal muscle development is severely
impaired in GNE2/2 mouse ES cells.
Sialic acid levels measurements
Sialic acid analysis of the membrane glycoprotein fractions of
300,000 cells showed the presence of Neu5Ac as well as trace
amounts of Neu5Gc in both samples, the analysis was performed
in duplicate and the average values are presented in Table 1. WT
ES cells contained approximately twice more Neu5Ac than the
GNE KO ES cells.
Discussion
In the context of the recessive disease Hereditary Inclusion
Body Myopathy (HIBM), caused by missense mutations in GNE,
we were interested in elucidating possible roles of GNE specifically
in skeletal muscle. The role of GNE in the sialic acid pathway has
been well established, as well as the importance of sialylation in
many diverse biological pathways mostly involving cell-cell
Figure 4. Cardiac muscle cells functionality. A –Beating rate of GNE+/+ (blue) and GNE2/2 (pink) cells foci. There is a decrease in the beating
pace of the GNE2/2 cells foci with time. B – Number of beating areas per 6well plate. The amount of beating foci in the GNE2/2 (pink) culture
decreases with time, compared to the GNE+/+ (blue) cells.
doi:10.1371/journal.pone.0021389.g004
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PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e21389Figure 5. Differentiation expression pattern of ES cells in culture. GNE+/+ (blue) and GNE2/2 (pink) ES cell cultures were analyzed for the
RNA expression of several differentiation markers, by RT-PCR: Oct4, as a pluripotent ES marker; neuro-filament medium (NFM), as a neuronal marker;
cardiac b-MyHC, as a cardiac cells marker;Pax7, as a skeletal muscle satellite cell marker and MyoD, as a skeletal muscle differentiating marker . b-
tubulin was used as a mouse house keeping gene. As a positive control murine muscle C2C12 cells, as well as heart and brain tissues from wild type
mouse were used (green panel).
doi:10.1371/journal.pone.0021389.g005
Figure 6. MyoR expression of ES cells in culture. GNE+/+ (blue) and GNE2/2 (pink) ES cell cultures were analyzed for the RNA expression of
MyoR by real time PCR at different timepoints. Expression is presented as relative quantity to MyoR mRNA of GNE+/+ ES at timepoint 0.
doi:10.1371/journal.pone.0021389.g006
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attempt to clarify whether GNE is directly involved in muscle
development, we have take advantage of the availability of GNE
KO ES cells derived from homozygous GNE KO embryos at day
E3.5 [15] and have compared their developing profile to GNE
homozygous normal ES cells. It has been shown previously that
spontaneous differentiation of mouse ES cells into various cell
types including cardiac and skeletal muscle as well as neuronal
cells is achieved by culturing the cells as aggregates (Embryoid
bodies, EBs) in differentiation medium with 1% DMSO, followed
by tissue culture plating [16].
In this study, we could recapitulate the time course development
of normal ES cells as reported before [16] and we found a strong
correlation between the morphology and the molecular data
presented.
As expected, we found that GNE has a great impact in the
development of neural cells; indeed the role of GNE and sialic acid
in brain development and plasticity has been well established. It has
been shown that the polysialic acid chain bound to the neural cell
adhesion molecule (NCAM) is responsible for the neural plasticity
during fetal development and in the brain of the adult [19–21]. Also
gangliosides have been found to strongly contribute to brain
development [22]. Our results confirm these findings. To date, no
data was available for assessing the role of GNE in muscle
development. The present findings suggest a very close to normal
development of cardiac cells which are even functional at the very
first stages of development, as determined by their morphology, the
expressionoftherelevant molecularmarkersand theirbeatingpace,
followed by a sharp loss of this functional property early after with
the appearance of senescence and degeneration symptoms. The fact
that at the beginning of differentiation (day 5+12) we cannot detect
differences in the number and the pace of the beating cells
appearing in both normal and GNE KO ES cells indicates that
GNE is not necessary for the development of individual functional
cells; however, their inability to generate fibers and their functional
decay and following degradation already at day 5+20 post
differentiation could indicate a defect in organization capacity,
expressed by the inability of the cells to form more sophisticated
structures. In this context it could be possible that GNE KO mice
die at day E8.5 because of defective cardiac function.
Figure 7. Impaired differentiation to skeletal muscle of GNE KO ES cells. GNE +/+ (A–C) and GNE2/2 (D–F) cell cultures were stained with
Myosin heavy chain (MyHC) antibody MF-20 (A1-F1) and Hoechst (A2-F2) at various stages of differentiation: A and D, day 5+12. B and E, day 5+20. C
and F, day 5+35 of differentiation. Normal skeletal muscle structures are absent in the GNE 2/2 cultures, only very short myotubes can be seen.
doi:10.1371/journal.pone.0021389.g007
Table 1. Sialic acid determination (in picomoles, pmol) of
GNE+/+ and GNE2/2 ES cells at timepoint 0, using DMB-
HPLC.
ES cells
Neu5Ac
(pmol)
Neu5Gc
(pmol)
GNE KO 160 19
GNE wt 314 2
doi:10.1371/journal.pone.0021389.t001
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to be affected even earlier. Normal ES cells can differentiate to
satellite skeletal muscle cells, as revealed by the expression of
Pax7, MyoD MyHC and MyoR in GNE+/+ cell cultures.
Although we could not detect clearly cells with skeletal muscle
morphology in either the GNE+/+ or the GNE2/2 cultures,
probably because the density of the cultures at this stage (only 5–
15% of the stem cells plated is expected to differentiate to skeletal
muscle cells [16], the expression analysis of Pax7 and MyoD
genes revealed very scarce muscle satellite cells and subsequently
an almost complete lack of cells committed to skeletal muscle
differentiation among GNE2/2 cells compared to GNE+/+
cells, as MyHC staining emphasized the lack of myotubes in these
GNE KO cultures. Further, MyoR expression was relatively high
in these cells. Musculin/MyoR is a negative transcription
regulator of satellite cell differentiation [18] and its inverse
correlation to MyoD expression could indeed support a
differentiation defect in GNE2/2 ES differentiating cells.
Skeletal muscle cell elongation and myotube formation seems to
be fully absent in our GNE2/2 cultures, although some cells
succeeded in reaching few more differentiated stages, as detected
in older cultures by very few and very short structures expressing
the MyHC protein. Thus, this data strongly supports a very early
and severe defect in cardiac and skeletal muscle development of
GNE2/2 cells.
Our studies clearly show the importance of GNE in the
development of embryonic stem cells derived muscle tissue
progenitors , both skeletal and cardiac. Indeed fiber generation
requires the concurrent recruitment of many biological processes
which involve a high number of proteins in the mature fiber for
the common and complex task of sarcomere organization. To
note, previous studies have point to a novel possible role for GNE
in muscle filament structures by proteomics analysis [23], and by
its capacity to bind to actinin1 next to the Z line as well as at the M
line [24]. The results of the present study strongly supports the
involvement of GNE in a novel function in sarcomere formation.
The question raises whether the dramatic effects on muscle
development are a direct consequence of the lack of this protein or
whether they are mediated by a lack of the sole known product
resulting from the enzymatic activity of GNE, sialic acid. Indeed, it
cannot be ruled out that sialic acid is the basic explanation of the
phenomenom, however the sialic content of the ES GNE2/2
cells is about half of the GNE+/+ cells; since sialic acid shows a
broad normal physiological range in human [10,11], and since
heterozygous GNE +/2 mice are healthy [14], it is highly unlikely
that the dramatic effects reported in our study could be accounted
for a relatively low reduction of the sialic acid level in the cells.
Therefore it is very likely that at least part of the cellular changes
seen in GNE2/2 ES cells compared to GNE+/+ ES cells occur
as a direct result of a GNE function(s) other than sialic acid
synthesis.
Interestingly, we have observed an increase of NeuGc in
GNE2/2 ES cells. The knockout of GNE results in the
inactivation of the synthesis of sialic acids using the de novo
pathway. In this situation, cells incorporate sialic acids stemming
from the cell culture medium into lysosomes where they are
released from exogenous glycoconjugates [25]. Free sialic acids are
then activated by CMP-Sia synthases (CMAS) and transferred to
glycoconjugates. Nystedt and coworkers [26] recently showed the
upregulation of CMP-Neu5Ac hydroxylase (CMAH), which
converts CMP-Neu5Ac into CMP-Neu5Gc, in human stem cells.
Therefore, the increase of NeuGc in ES GNE2/2 cells compared
to GNE+/+ cells might be explained by the upregulation of
CMAH.
Although our results do not clarify the function of GNE in later
stages of muscle development, accumulating evidence is pointing
to novel GNE functions in addition to its well established and
investigated role as a bifunctional key enzyme in the sialic acid
pathway. First, its ability to regulate sialyl transferases [27];
second, its binding capacities to a-actinin1 in skeletal muscle [24],
and very recently, its involvement in neurite differentiation [28]
and in proliferation of ES cells [15]. Also the present studies show
that the proliferation, adherence and/or migration and tissue
organization capacities of GNE2/2 ES cells are defective at their
very first stages of differentiation.
HIBM is a slowly progressive, adult onset disorder, character-
ized by skeletal muscle atrophy solely. The disease results from
missense mutations in GNE, and the entire mutated protein is
present at normal levels and at the appropriate location in
patients’skeletal muscles [8,9]. The first hypothesis considered in
HIBM pathogenesis is a change in the sialylation pattern
potentially caused by a defective GNE activity. However,
investigations of the GNE enzymatic functions showed that the
extent of the activity reduction in lymphocytes, myoblasts and
myotubes of HIBM patients varied only around 30%, [10,11]
making it difficult to explain how such partial enzymatic activity
reduction could lead to markedly reduced sialic acid production:
indeed it has been shown that in normal tissue GNE activity
consists of only 5% of its potential [27] and theoretically this
could be augmented in HIBM by compensatory activation;
furthermore, additional kinases present in the cell, such as N
acetyl glucosamine kinase (NAGK), are capable to use N acetyl
mannosamine as a substrate [29] and therefore could compensate
for the partial defective function of the kinase activity of GNE, at
least in HIBM cells carrying the homozygous M712T mutation at
the kinase domain, which is the common Middle Eastern
mutation. Further, HIBM is an adult onset disorder, thus
excluding the possibility of early important developmental
defects, which would be expected as the result of the involvement
of sialic acid dysfunction, which most likely would present a more
severe and early phenotype.
Various directions have been undertaken to try and unravel
novel potential functions for GNE, which could lead to better
insights into the pathogenesis of HIBM. Among those, satellite cell
dysfunction [30], modulatory effects on other biochemical
pathways [27], a yet undetermined nuclear activity [9,31] and
recently identified protein partners [24,32] are to be noted.
Certainly the essential role of GNE involving sarcomere
organization, maintenance and robustness in the development of
cardiac and skeletal muscle showed here, will bring novel
understandings in muscle function mechanisms.
Supporting Information
Video S1 Functional cardiac cells in cultures of normal (N ES)
and GNE KO ES (KO ES) cells at day 5+12 post differentiation.
Both cell types contract at similar pace.
(MPG)
Video S2 Functional cardiac cells in cultures of normal (N ES)
and GNE KO ES (KO ES) cultures at day 5+30 post
differentiation. Normal cells contract at the same pace than at
day 5+12, in contrast GNE KO cells contractions are much
slower.
(MPG)
Table S1 Primer sequences used for analysis of expression
markers.
(DOC)
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